GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (STU:93Z) » Definitions » Forward Dividend Yield %

Marinomed Biotech AG (STU:93Z) Forward Dividend Yield % : 0.00% (As of Dec. 11, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Marinomed Biotech AG Forward Dividend Yield %?

As of today (2024-12-11), the Forward Annual Dividend Yield of Marinomed Biotech AG is 0.00%.

As of today (2024-12-11), the Trailing Annual Dividend Yield of Marinomed Biotech AG is 0.00%.

STU:93Z's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.47
* Ranked among companies with meaningful Forward Dividend Yield % only.

Marinomed Biotech AG's Dividends per Share for the three months ended in Mar. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Marinomed Biotech AG's Forward Dividend Yield %

For the Biotechnology subindustry, Marinomed Biotech AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marinomed Biotech AG's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marinomed Biotech AG's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Marinomed Biotech AG's Forward Dividend Yield % falls into.



Marinomed Biotech AG Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Marinomed Biotech AG  (STU:93Z) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Marinomed Biotech AG Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Marinomed Biotech AG Business Description

Traded in Other Exchanges
Address
Hovengasse 25, Korneuburg, AUT, 2100
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generated from the virology segment.

Marinomed Biotech AG Headlines

No Headlines